PlainPill

Melatonin

The short answer. People are split on Melatonin — 42% of 726 say it helped. It is most often used for sleep: 78% of 915 reports say that improved. It is well studied — 688 meta-analyses on PubMed. The most common complaint is drowsiness.

What users report
42%helped726 reports · high confidence
301 helped274 mixed151 didn't help

From 1,370 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
688
meta-analyses
1,128
RCTs
35,874
papers

What Melatonin does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 688 meta-analyses on PubMed ↗ · 1,128 randomized trials ↗

Lancet · 2022 · Meta-analysis / systematic review
Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

Conclusion: Overall, eszopiclone and lemborexant had a favorable profile, but eszopiclone might cause substantial adverse events and safety data on lemborexant were inconclusive. Doxepin, seltorexant, and zaleplon were well tolerated, but data on efficacy and other important outcomes were scarce and do not allow firm conclusions. Many licensed drugs (including benzodiazepines, daridorexant, suvorexant, and trazodone) can be effective in the acute treatment of insomnia but are associated with poor tolerability, or information about long-term effects is not available. Melatonin, ramelteon, and non-licensed

PubMed 35843245 ↗
J Neurol · 2022 · Meta-analysis / systematic review
Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials

Conclusion: We found that the treatment with exogenous melatonin has positive effects on sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI) in adult. In adults with respiratory diseases, metabolic disorders, primary sleep disorders, not with mental disorders, neurodegenerative diseases and other diseases.

PubMed 33417003 ↗
J Pineal Res · 2024 · Meta-analysis / systematic review
Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis

Conclusion: Meta-regression models showed that insomnia status (β = 0.50, p < 0.001) and time between treatment administration and the sleep episode (β = -0.16, p = 0.023) were significant predictors of sleep onset latency, while the time of day (β = -0.086, p < 0.01) was the only significant predictor of total sleep time. Our results suggest that advancing the timing of administration (3 h before the desired bedtime) and increasing the administered dose (4 mg/day), as compared to the exogenous melatonin schedule most used in clinical practice (2 mg 30 min before the desired bedtime), might optimize the e

PubMed 38888087 ↗
Crit Care Med · 2025 · Meta-analysis / systematic review
Melatonin Use in the ICU: A Systematic Review and Meta-Analysis

Conclusion: Our findings suggest that melatonin administration in the critically ill may improve perceived sleep and reduce delirium, without increasing adverse effects. Certainty of evidence was negatively affected by the risk of bias and inconsistency. Future RCTs should focus on identifying optimal dosing, administration timing, improving measurements of sleep outcomes, and target populations.

PubMed 40662882 ↗
Registered clinical trials

720 human trials on ClinicalTrials.gov test Melatonin — 361 completed, 86 recruiting now. See all on ClinicalTrials.gov ↗

Reports to the FDA

Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.

370 reports name a product containing Melatonin (2004–2026); 129 involved hospitalization or worse. Most often reported:

  • Dizziness · 36
  • Nausea · 34
  • Insomnia · 30
  • Dyspnoea · 29
  • Diarrhoea · 29
  • Headache · 27

A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA recalls

10 recalls of products named for Melatonin. Most recent:

  • 2022-08-10 · Class II: Acidified/Low Acid dietary supplement with no approved process. record ↗
  • 2022-02-16 · Class II: cGMP Deviations record ↗
  • 2021-05-12 · Class II: One lot of ALA 300 mg Cap-50 were labeled at Melatonin 3 mg Tab-60. record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Melatonin E — an unlikely cause of liver injury. LiverTox entry ↗

Approved claims in Canada (Health Canada)
  • (Used as a) sleep aid (to help promote sleep).
  • Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag).
  • Helps (to) prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people/if travelling by plane easterly across two or more time zones/flying east over two or more time zones).
  • Helps (to) speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder.

Required cautions: When using this product avoid taking with alcohol or products that cause drowsiness. When using this product avoid driving or using machinery for 5 hours. Ask a health care practitioner if sleeplessness persists for more than 4 weeks (chronic insomnia).

Health Canada monograph: Melatonin - Oral ↗

Health claims in the EU (European Commission)

2 authorised claims, e.g.:

  • Melatonin contributes to the alleviation of subjective feelings of jet lag register ↗
  • Melatonin contributes to the reduction of time taken to fall asleep register ↗

1 proposed claim was rejected, usually because EFSA found the evidence insufficient (example ↗).

US government research funding (NIH)

NIH has funded 208 research projects with Melatonin in the title, $119,757,682 in total (1985–2026). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

0.5 mgbedtime
0.3-3 mgnightly
2-5 mgnightly
3 mgnightly
3 mg - 2000 mgnightly
3 mgdaily

Reported side effects

How often each side effect came up across all reports.

drowsiness ×127vivid dreams ×86fatigue ×30depression ×17brain fog ×15headache ×6suppression ×3stomach issues ×2

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“I have taken it nightly for 19 years. Doses ranging from .1 to 10mg. Right now I take 3mg per night. It helps me sleep.”
HelpedRead the discussion ↗
“A small dose 0.3mg works for me way better than higher doses.”
MixedRead the discussion ↗
“I tried 1mg melatonin and this almost doubled my REM sleep but deep sleep stayed the same.”
MixedRead the discussion ↗
“I used to take 50 mg before bedtime but now run out of it and use Dramamine instead. Sleep 8 hours. But with Melatonin dreams are more colourful.”
MixedRead the discussion ↗
Read more Melatonin reviews →
Top discussions (5)

Melatonin compared

Other options for sleep

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate